Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,151
Closed -$13.3K 1318
2024
Q1
$13.3K Buy
1,151
+43
+4% +$570 ﹤0.01% 1305
2023
Q4
$18.3K Buy
1,108
+88
+9% +$1.46K ﹤0.01% 1268
2023
Q3
$23K Buy
1,020
+27
+3% +$766 ﹤0.01% 1230
2023
Q2
$31.8K Buy
993
+105
+12% +$3.36K ﹤0.01% 1242
2023
Q1
$26.5K Hold
888
﹤0.01% 1207
2022
Q4
$41.8K Buy
888
+75
+9% +$3.81K ﹤0.01% 1190
2022
Q3
$33K Buy
813
+78
+11% +$3.98K ﹤0.01% 1164
2022
Q2
$28K Buy
735
+204
+38% +$7.41K ﹤0.01% 1172
2022
Q1
$26K Buy
531
+5
+1% +$270 ﹤0.01% 1153
2021
Q4
$33K Buy
+526
New +$41.5K ﹤0.01% 1161
2021
Q3
Sell
-550
Closed -$59K 1173
2021
Q2
$59K Buy
+550
New +$41.2K ﹤0.01% 1228

Other funds holding AGEN

Xponance's AGEN Position: Q2 2024 in Review

Xponance sold out of Agenus (AGEN) in Q2 2024, closing a stake of 1,151 shares — an estimated $13.3K sold.

Xponance first reported a position in AGEN in Q2 2021 and held it in 11 quarters. The position peaked at $59K in Q2 2021. 89 funds tracked by Wall St. Rank hold AGEN as of Q2 2024.

  • Xponance reported no remaining Agenus position as of Q2 2024 after selling out during the quarter.
  • Xponance sold 1,151 Agenus shares in Q2 2024, an estimated $13.3K.
  • Xponance first reported a position in Agenus in Q2 2021 and held it in 11 quarters.
  • Xponance's Agenus position peaked at $59K in Q2 2021.
  • 89 funds tracked by Wall St. Rank held Agenus as of Q2 2024.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.